SG3-25243-53409 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Dose 1 — Pfizer-BioNTech
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-21
Registered in v-safe
2021-01-21
Health check-in — day 7, dose 2
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-02-03
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-02-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-18
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-02-23
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-13
Survey response — 6 months, dose 2
MedDRA: HELLP syndrome, Pre-eclampsia, Premature delivery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Preeclampsia, hellp syndrome, early delivery at 33 weeks

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech

Free text

Release 9 — 6 months, dose 2

2021-07-13

Symptoms: Preeclampsia, hellp syndrome, early delivery at 33 weeks

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	HELLP syndrome	✓	✓	✓
SD	Pre-eclampsia	✓	✓	✓
SD	Premature delivery	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release